Article Text

PDF

Double blind randomised controlled trial of two different breathing techniques in the management of asthma
  1. C A Slader1,
  2. H K Reddel2,
  3. L M Spencer3,
  4. E G Belousova2,
  5. C L Armour4,
  6. S Z Bosnic-Anticevich4,
  7. F C K Thien5,
  8. C R Jenkins2
  1. 1Co-operative Research Centre for Asthma, University of Sydney, and Faculty of Pharmacy, University of Sydney, Australia
  2. 2Co-operative Research Centre for Asthma, University of Sydney, and Woolcock Institute of Medical Research, Camperdown, Australia
  3. 3Department of Physiotherapy, Royal Prince Alfred Hospital, Camperdown, Australia
  4. 4University of Sydney, Sydney, Australia
  5. 5Co-operative Research Centre for Asthma, Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, and Monash University, Melbourne, Australia
  1. Correspondence to:
    C A Slader
    Faculty of Pharmacy, University of Sydney, New South Wales, Australia 2006; cassandra{at}pharm.usyd.edu.au

Abstract

Background: Previous studies have shown that breathing techniques reduce short acting β2 agonist use and improve quality of life (QoL) in asthma. The primary aim of this double blind study was to compare the effects of breathing exercises focusing on shallow nasal breathing with those of non-specific upper body exercises on asthma symptoms, QoL, other measures of disease control, and inhaled corticosteroid (ICS) dose. This study also assessed the effect of peak flow monitoring on outcomes in patients using breathing techniques.

Methods: After a 2 week run in period, 57 subjects were randomised to one of two breathing techniques learned from instructional videos. During the following 30 weeks subjects practised their exercises twice daily and as needed for relief of symptoms. After week 16, two successive ICS downtitration steps were attempted. The primary outcome variables were QoL score and daily symptom score at week 12.

Results: Overall there were no clinically important differences between the groups in primary or secondary outcomes at weeks 12 or 28. The QoL score remained unchanged (0.7 at baseline v 0.5 at week 28, p = 0.11 both groups combined), as did lung function and airway responsiveness. However, across both groups, reliever use decreased by 86% (p<0.0001) and ICS dose was reduced by 50% (p<0.0001; p>0.10 between groups). Peak flow monitoring did not have a detrimental effect on asthma outcomes.

Conclusion: Breathing techniques may be useful in the management of patients with mild asthma symptoms who use a reliever frequently, but there is no evidence to favour shallow nasal breathing over non-specific upper body exercises.

  • ACQ, Asthma Control Questionnaire
  • AQLQ, Asthma Quality of Life Questionnaire
  • FEV1, forced expiratory volume in 1 second
  • FVC, forced vital capacity
  • ICS, inhaled corticosteroid
  • PEF, peak expiratory flow
  • asthma
  • complementary medicine
  • breathing techniques
  • Buteyko
  • randomised controlled trial
View Full Text

Statistics from Altmetric.com

Supplementary materials

  • Files in this Data Supplement:

Footnotes

  • Published Online First 5 June 2006

  • This study was conducted under the auspices of the Cooperative Research Centre for Asthma, jointly funded by the Australian Federal Government and industry, including AstraZeneca, Aventis Pharma, and GlaxoSmithKline. HR was funded by the Asthma Foundation of New South Wales. CS was funded by the Australian Government Department of Education, Science and Training via an Australian Postgraduate Award.

  • Competing interests: none.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Airwaves
    Wisia Wedzicha